Anzeige
Mehr »
Login
Dienstag, 29.11.2022 Börsentäglich über 12.000 News von 681 internationalen Medien
Breaking News! Rallye und Ausbruch die logische Konsequenz?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoAlmirall joins project to allow study participants to use trial data
MoC4XD signs NRF2 Activator deal with AstraZeneca
FrBristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation
FrDepressive therapy Spravato demonstrates superior efficacy
DoStorm doses first patient with solid tumour drug candidate
DoMulti-drug precision medicine cancer trial begins
MiStudy brings personalised immunotherapy prescriptions closer
MiMedicines for Malaria Venture and Novartis move to phase 3 trial
22.11.Takeda findings may minimise haemophilia treatment side effects
22.11.Turbine boosts AI platform to deliver cancer treatments
21.11.Infex begins study of pseudomonas aeruginosa candidate RESP-X
21.11.Iveric Bio receives new therapy designation for avacincaptad pegol
18.11.NICE recommends Sobi's Doptelet to treat thrombocytopenia
18.11.Kidney Cancer UK receives commission from NICE
17.11.Association of the British Pharmaceutical Industry lays down new antibiotics mission
17.11.NICE recommends Pfizer's Paxlovid on NHS
16.11.Evgen to investigate new SFX-01 tablet formulation
16.11.Research provides hope for patients with neurodegenerative disease
15.11.Sequana announces results from study of direct sodium removal
15.11.Norfolk and Norwich University Hospitals establishes therapy for ovarian cancer patients
14.11.Lindis biotech presents encouraging data from bladder cancer trial
14.11.Priothera reveals positive mocravimod data
11.11.Stada and Xbrane gain EU approval for biosimilar Ximluci
11.11.Bristol Myers Squibb opens 125-acre biologics campus in Dublin
10.11.Brainomix and Visionable announce AI partnership